Search research articles
Contact Us
Filters
Showing results (151-160 of 513) with videos related to
Page
of 52
Sort By:
Journal of Crohn'S & Colitis
|
May 28, 2013
Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center
Andrew Tinsley, Steven Naymagon, Laura M Enomoto, et al.
The Journal of Biological Chemistry
|
April 21, 1995
Molecular cloning of the rat intestinal trefoil factor gene. Characterization of an intestinal goblet cell-associated promoter
B E Sands, H Ogata, K Lynch-Devaney, et al.
Scandinavian Journal of Gastroenterology
|
June 26, 2020
Ileocolic anastomotic inflammation after resection for Crohn's disease indicates disease recurrence: a histopathologic study
Robert P Hirten, Simran Mashiana, Benjamin L Cohen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 7, 2022
Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis
Parambir S Dulai, Brian G Feagan, Bruce E Sands, et al.
Clinical Pharmacology and Therapeutics
|
March 15, 2024
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions
Jie Shao, Marion Vetter, An Vermeulen, et al.
Journal of Crohn'S & Colitis
|
December 26, 2014
High-dose infliximab therapy in Crohn's disease: clinical experience, safety, and efficacy
Steven A Hendler, Benjamin L Cohen, Jean-Frédéric Colombel, et al.
Evolutionary Human Sciences
|
October 15, 2025
Tracing contact and migration in pre-Bantu Southern Africa through lexical borrowing
Anne-Maria Fehn, Bonny E Sands, Admire Phiri, et al.
Journal of Crohn'S & Colitis
|
July 12, 2023
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis
Bruce E Sands, Stefan Schreiber, Irina Blumenstein, et al.
Gastroenterology
|
February 5, 2008
Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis
Gilaad G Kaplan, Ellen P McCarthy, John Z Ayanian, et al.
Inflammatory Bowel Diseases
|
November 18, 2009
Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease
Bruce E Sands, Eric W Jacobson, Thomas Sylwestrowicz, et al.
Page
of 52
Search research articles
Search
Showing results (151-160 of 513) with videos related to
Sort By:
Page
of 52
Journal of Crohn'S & Colitis
|
May 28, 2013
Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center
Andrew Tinsley, Steven Naymagon, Laura M Enomoto, et al.
The Journal of Biological Chemistry
|
April 21, 1995
Molecular cloning of the rat intestinal trefoil factor gene. Characterization of an intestinal goblet cell-associated promoter
B E Sands, H Ogata, K Lynch-Devaney, et al.
Scandinavian Journal of Gastroenterology
|
June 26, 2020
Ileocolic anastomotic inflammation after resection for Crohn's disease indicates disease recurrence: a histopathologic study
Robert P Hirten, Simran Mashiana, Benjamin L Cohen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 7, 2022
Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis
Parambir S Dulai, Brian G Feagan, Bruce E Sands, et al.
Clinical Pharmacology and Therapeutics
|
March 15, 2024
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions
Jie Shao, Marion Vetter, An Vermeulen, et al.
Journal of Crohn'S & Colitis
|
December 26, 2014
High-dose infliximab therapy in Crohn's disease: clinical experience, safety, and efficacy
Steven A Hendler, Benjamin L Cohen, Jean-Frédéric Colombel, et al.
Evolutionary Human Sciences
|
October 15, 2025
Tracing contact and migration in pre-Bantu Southern Africa through lexical borrowing
Anne-Maria Fehn, Bonny E Sands, Admire Phiri, et al.
Journal of Crohn'S & Colitis
|
July 12, 2023
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis
Bruce E Sands, Stefan Schreiber, Irina Blumenstein, et al.
Gastroenterology
|
February 5, 2008
Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis
Gilaad G Kaplan, Ellen P McCarthy, John Z Ayanian, et al.
Inflammatory Bowel Diseases
|
November 18, 2009
Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease
Bruce E Sands, Eric W Jacobson, Thomas Sylwestrowicz, et al.
Page
of 52